The p38 mitogen-activated protein kinase pathway links the DNA mismatch repair system to the G2 checkpoint and to resistance to chemotherapeutic DNA-methylating agents

被引:117
作者
Hirose, Y
Katayama, M
Stokoe, D
Haas-Kogan, DA
Berger, MS
Pieper, RO
机构
[1] Univ Calif San Francisco, Ctr Canc, Dept Neurol Surg, San Francisco, CA 94115 USA
[2] Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94115 USA
关键词
D O I
10.1128/MCB.23.22.8306-8315.2003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although human cells exposed to DNA-methylating agents undergo mismatch repair (MMR)-dependent G(2) arrest, the basis for the linkage between MMR and the G(2) checkpoint is unclear. We noted that mitogen-activated protein kinase p38alpha was activated in MMR-proficient human glioma cells exposed to the chemotherapeutic methylating agent temozolomide (TMZ) but not in paired cells made MMR deficient by expression of a short inhibitory RNA (siRNA) targeted to the MMR protein Mlh1. Furthermore, activation of p38a in MMR-proficient cells was associated with nuclear inactivation of the cell cycle regulator Cdc25C phosphatase and its downstream target Cdc2 and with activation of the G(2) checkpoint, actions which were suppressed by the p38alpha/beta inhibitors SB203580 and SB202590 or by expression of a p38alpha siRNA. Finally, pharmacologic or genetic inhibition of p38alpha increased the sensitivity of MMR-proficient cells to the cytotoxic actions of TMZ by increasing the percentage of cells that underwent mitotic catastrophe as a consequence of G(2) checkpoint bypass. These results suggest that p38alpha links DNA MMR to the G(2) checkpoint and to resistance to chemotherapeutic DNA-methylating agents. The p38 pathway may therefore represent a new target for the development of agents to sensitize tumor cells to chemotherapeutic methylating agents.
引用
收藏
页码:8306 / 8315
页数:10
相关论文
共 55 条
[1]   ATM is activated in response to N-methyl-N′-nitro-N-nitrosoguanidine-induced DNA alkylation [J].
Adamson, AW ;
Kim, WJ ;
Shangary, S ;
Baskaran, R ;
Brown, KD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (41) :38222-38229
[2]   Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific [J].
Baudhuin, LM ;
Cristina, KL ;
Lu, J ;
Xu, Y .
MOLECULAR PHARMACOLOGY, 2002, 62 (03) :660-671
[3]   Functional interactions and signaling properties of mammalian DNA mismatch repair proteins [J].
Bellacosa, A .
CELL DEATH AND DIFFERENTIATION, 2001, 8 (11) :1076-1092
[4]   Unmasking a killer:: DNA O6-methylguanine and the cytotoxicity of methylating agents [J].
Bignami, M ;
O'Driscoll, M ;
Aquilina, G ;
Karran, P .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2000, 462 (2-3) :71-82
[5]   CANCER-RESEARCH CAMPAIGN PHASE-II TRIAL OF TEMOZOLOMIDE IN METASTATIC MELANOMA [J].
BLEEHEN, NM ;
NEWLANDS, ES ;
LEE, SM ;
THATCHER, N ;
SELBY, P ;
CALVERT, AH ;
RUSTIN, GJS ;
BRAMPTON, M ;
STEVENS, MFG .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (04) :910-913
[6]   DEFECTIVE MISMATCH BINDING AND A MUTATOR PHENOTYPE IN CELLS TOLERANT TO DNA DAMAGE [J].
BRANCH, P ;
AQUILINA, G ;
BIGNAMI, M ;
KARRAN, P .
NATURE, 1993, 362 (6421) :652-654
[7]  
BRANCH P, 1995, CANCER RES, V55, P2304
[8]   The mismatch repair system is required for S-phase checkpoint activation [J].
Brown, KD ;
Rathi, A ;
Kamath, R ;
Beardsley, DI ;
Zhan, QM ;
Mannino, JL ;
Baskaran, R .
NATURE GENETICS, 2003, 33 (01) :80-84
[9]   Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase [J].
Bulavin, DV ;
Higashimoto, Y ;
Popoff, IJ ;
Gaarde, WA ;
Basrur, V ;
Potapova, O ;
Appella, E ;
Fornace, AJ .
NATURE, 2001, 411 (6833) :102-107
[10]   14-3-3σ is required to prevent mitotic catastrophe after DNA damage [J].
Chan, TA ;
Hermeking, H ;
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
NATURE, 1999, 401 (6753) :616-620